Incidence of food anaphylaxis in people with food allergy: a systematic review and meta-analysis

Department of Paediatrics, Imperial College London, Norfolk Place, London, W2 1PG, UK
Clinical & Experimental Allergy (Impact Factor: 4.32). 10/2013; 43(12). DOI: 10.1111/cea.12211
Source: PubMed

ABSTRACT Food allergy is a common cause of anaphylaxis, but the incidence of fatal food anaphylaxis is not known. The aim of this study was to estimate the incidence of fatal food anaphylaxis for people with food allergy, and relate this to other mortality risks in the general population.
We undertook a systematic review and meta-analysis, using the generic inverse variance method. Two authors selected studies by consensus, independently extracted data, and assessed the quality of included studies using the Newcastle-Ottawa assessment scale. We searched Medline, Embase, PsychInfo, CINAHL, Web of Science, LILACS or AMED, between January 1946 and September 2012, and recent conference abstracts. We included registries, databases or cohort studies which described the number of fatal food anaphylaxis cases in a defined population and time period, and applied an assumed population prevalence rate of food allergy.
We included data from 13 studies describing 240 fatal food anaphylaxis episodes over an estimated 165 million food-allergic person years. Study quality was mixed, and there was high heterogeneity between study results, possibly due to variation in food allergy prevalence and data collection methods. In food allergic people, fatal food anaphylaxis has an incidence rate of 1.81 per million person years (95%CI 0.94, 3.45; range 0.63, 6.68). In sensitivity analysis with different estimated food allergy prevalence, the incidence varied from 1.35 to 2.71 per million person years. At age 0-19 the incidence rate is 3.25 (1.73, 6.10; range 0.94, 15.75; sensitivity analysis 1.18 to 6.13). The incidence of fatal food anaphylaxis in food allergic people is lower than accidental death in the general European population.
Fatal food anaphylaxis for a food allergic person is rarer than accidental death in the general population. This article is protected by copyright. All rights reserved.


Available from: John O Warner, Sep 23, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There are no prospectively collected data available on the natural history of peanut allergy in early childhood. Previous studies of predictors of tolerance development have been biased by failure to challenge high-risk children when IgE antibody levels are high, therefore potentially introducing bias to persistent allergy. We sought to describe the natural history of peanut allergy between 1 and 4 years of age and develop thresholds for skin prick test (SPT) results and specific IgE (sIgE) levels measured at age 1 and 4 years that have 95% positive predictive value (PPV) or negative predictive value for the persistence or resolution of peanut allergy. One-year-old infants with challenge-confirmed peanut allergy (n = 156) from the population-based, longitudinal HealthNuts Study (n = 5276) were followed up at 4 years of age with repeat oral food challenges, SPTs, and sIgE measurements (n = 103). Challenges were undertaken in all peanut-sensitized children at 1 and 4 years of age, irrespective of risk profile. Peanut allergy resolved in 22% (95% CI, 14% to 31%) of children by age 4 years. Decreasing wheal size predicted tolerance, and increasing wheal size was associated with persistence. Thresholds for SPT responses and sIgE levels at age 1 year with a 95% PPV for persistent peanut allergy are an SPT-induced response of 13 mm or greater and an sIgE level of 5.0 kU/L or greater. Thresholds for SPT and sIgE results at age 4 years with a 95% PPV for persistent peanut allergy are an SPT response of 8 mm or greater and an sIgE level of 2.1 kU/L or greater. Ara h 2, tree nut, and house dust mite sensitization; coexisting food allergies; eczema; and asthma were not predictive of persistent peanut allergy. These thresholds are the first to be generated from a unique data set in which all participants underwent oral food challenges at both diagnosis and follow-up, irrespective of SPT and sIgE results. Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
    Journal of Allergy and Clinical Immunology 02/2015; 135(2). DOI:10.1016/j.jaci.2015.01.002 · 11.25 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract: Die Diagnose einer Nahrungsmittelallergie hat für Patienten in der Regel eine große Bedeutung. Sie führt zum einen zu einer Einschränkung in der Lebensführung durch die notwendigen Diäten. Zum anderen aber ist sie in vielen Fällen mit einem ständigen Bedrohungsszenario verbunden, da plötzliche allergische Reaktionen bis hin zu einer lebensgefährlichen Anaphylaxie drohen. Es ist für die Patienten essenziell, im Umgang mit Notfallsituationen geschult zu sein und die richtigen Entscheidungen über den Einsatz der Notfallmedikamente zu treffen. Bei guter Aufklärung treten schwere allergische Reaktionen aber nur selten auf. Die resultierende Angst führt zu einer signifikanten Beeinträchtigung der Lebensqualität. In den letzten Jahren sind viele Untersuchungen zur Lebensqualität von Patienten mit Nahrungsmittelallergie und Anaphylaxie durchgeführt worden. Sie helfen, das Verhalten der Patienten in ihrem Alltag zu verstehen. Sie ermöglichen vor allem, durch eine gezielte und bewusste Beratung die Einschränkung der Lebensqualität zu reduzieren und Meidungsverhalten und Compliance hinsichtlich der notwendigen Notfallmaßnahmen zu verbessern. In diesem Artikel werden die vorhandenen Daten zusammengefasst und Empfehlungen formuliert, die helfen können, die Betreuung von Patienten mit Nahrungsmittelallergie hinsichtlich ihrer Lebensqualität und der Compliance zu verbessern.
    11/2014; 23(4):252-260. DOI:10.1007/s40629-014-0029-x
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The incidence of anaphylaxis might be increasing. Data for fatal anaphylaxis are limited because of the rarity of this outcome. We sought to document trends in anaphylaxis admissions and fatalities by age, sex, and cause in England and Wales over a 20-year period. We extracted data from national databases that record hospital admissions and fatalities caused by anaphylaxis in England and Wales (1992-2012) and crosschecked fatalities against a prospective fatal anaphylaxis registry. We examined time trends and age distribution for fatal anaphylaxis caused by food, drugs, and insect stings. Hospital admissions from all-cause anaphylaxis increased by 615% over the time period studied, but annual fatality rates remained stable at 0.047 cases (95% CI, 0.042-0.052 cases) per 100,000 population. Admission and fatality rates for drug- and insect sting-induced anaphylaxis were highest in the group aged 60 years and older. In contrast, admissions because of food-triggered anaphylaxis were most common in young people, with a marked peak in the incidence of fatal food reactions during the second and third decades of life. These findings are not explained by age-related differences in rates of hospitalization. Hospitalizations for anaphylaxis increased between 1992 and 2012, but the incidence of fatal anaphylaxis did not. This might be due to increasing awareness of the diagnosis, shifting patterns of behavior in patients and health care providers, or both. The age distribution of fatal anaphylaxis varies significantly according to the nature of the eliciting agent, which suggests a specific vulnerability to severe outcomes from food-induced allergic reactions in the second and third decades. Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.
    Journal of Allergy and Clinical Immunology 11/2014; DOI:10.1016/j.jaci.2014.10.021 · 11.25 Impact Factor